Torrent Pharmaceuticals Ltd.
TORNTPHARM
Torrent Pharmaceuticals Ltd. Share Price
4,898.30 -121.20 (-2.41%)Incorporated in 1972, Torrent Pharmaceutical Limited, an Indian multinational within the Torrent group, excels in pharmaceutical development and marketing. Through a patent-centric approach to healthcare, the company aims to bring state of the art pharma solutions through incremental innovation, niche marketing and speciality focus. It is based in Ahmedabad, India.
The company’s primary channel of distribution is through wholesale drug distributors and retail pharmacies.
Business Segment
The company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations.
Therapeutic Segments: such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynaecology, and dermatology.
- Pediatric Brand Portfolio: include Tedibar, Atogla, Spoo and B4 Nappi
- Acne/Facecare Brand Portfolio: offers Clinmiskin, ACNEMOIST, TRACNILO and fash
- Hair/Scalp Care Brand Portfolio: Proanagen, Perlice, Permite and NOSKURF
Manufacturing Facilities: are in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim
Geographical Presence
The company caters within and outside India.
Fundamentals
Market Cap₹1,87,267Cr | EPS₹63.92 |
Book Value/Share₹221.11 | P/E Ratio (TTM)78.54 |
Industry P/E (TTM)46.93 | P/B Ratio20.25 |
Long Term D/E1.79 | ROE27.07% |
Dividend Yield (TTM)0.80% |
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Strong Outperformer
Very Expensive
Excellent Quality
Low Price Fluctuation
Analysts are Very Bullish
Peer Comparison
Peer comparison lists companies from the same sector, scored and ranked based on Crisp Analysis. It helps understand how a company stands against its competitors.
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Torrent Pharmaceuticals Ltd.
The share price of Torrent Pharmaceuticals Ltd. is ₹4,898.30 on NSE as of 28/7/2026, 8:32:50 pm. Share prices may change frequently due to market movements.
The market capitalisation of Torrent Pharmaceuticals Ltd. is ₹1,87,267Cr as of 28/7/2026, 8:32:50 pm
The current Price to Earnings (P/E) ratio of Torrent Pharmaceuticals Ltd. is 78.54 as of 28/7/2026, 8:32:50 pm
The Price to Book (P/B) ratio of Torrent Pharmaceuticals Ltd. stands at 20.25 as of 28/7/2026, 8:32:50 pm
Torrent Pharmaceuticals Ltd. reported an ROE of 27.08% for the last reported financial year on a consolidated account basis.
As of 28/7/2026, 8:32:50 pm, Torrent Pharmaceuticals Ltd.’s shareholding pattern is: promoters hold 68.30%, FIIs hold 15.40%, DIIs hold 5.00%, and public shareholders hold 6.40%.
The 52-week high of Torrent Pharmaceuticals Ltd. is ₹5,040.00 and the 52-week low is ₹4,866.00 as of 28/7/2026, 8:32:50 pm.
The earnings per share (EPS) of Torrent Pharmaceuticals Ltd. is ₹11.51 for the quarter ended Mar 2026.
The stock symbol of Torrent Pharmaceuticals Ltd. is TORNTPHARM.
You can buy Torrent Pharmaceuticals Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Torrent Pharmaceuticals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Q/Q Change |
|---|---|---|
| Operating Revenue | 4,197.00 | +27.07% |
| Other Income | -17.00 | +30.77% |
| Total Income | 4,180.00 | +27.05% |
| Total Expenditure | 2,841.00 | +28.26% |
| EBIDT | 1,273.00 | +19.53% |
| Depreciation | 508.00 | +146.60% |
| Interest | 236.00 | +424.44% |
| Tax | 165.00 | -7.82% |
| Net Profit | 389.00 | -38.74% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 9,393.09 |
| Total Non-Current Assets | 34,918.87 |
| Fixed assets | 29,842.68 |
| Total Assets | 44,311.96 |
| Total Current liabilities | 8,343.33 |
| Total Non Current Liabilities | 18,383.80 |
| Total Equity Plus Liabilities | 44,311.96 |
| Total Shareholder Funds | 8,388.43 |
| Total Debt to Equity | 176.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 3,022.71 |
| Cash from Financing Activities | 10,150.60 |
| Cash from Investing Activities | -12,712.41 |
| Net Cash Flow | 460.90 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages11
Bearish Moving Averages5
5 Day
5,024.1010 Day
4,986.8020 Day
4,892.7030 Day
4,759.8050 Day
4,634.00100 Day
4,443.20150 Day
4,294.20200 Day
4,138.40Indicators
RSI (14)
62.05MACD (12, 26)
120.97MACD Signal Line (9)
124.39MFI (14)
44.20ATR (14)
134.03ADX (14)
30.46ROC (21)
11.14ROC (125)
26.06Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 5,072.40 | 5,125.30 | 5,180.60 | 5,017.10 | 4,964.20 | 4,908.90 | 4,856.00 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Torrent Pharmaceuticals Ltd.
TORNTPHARM
Open Price | 5,020.10 |
Prev Close | 5,019.50 |
Upper Circuit | 5,521.40 |
Lower Circuit | 4,517.60 |
Volume | 5,49,152 |
Average Traded Price | 4,912.67 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |